Nemiroff Alex, an insider at Praxis Precision Medicines Inc (PRAX), sold 29,932 shares of the company on November 19, 2025, at a price of $193.23 per share. The total value of the transaction reached $5.78 million. Following this sale, Nemiroff retains 29,932 shares in the company.
Praxis Precision Medicines, based in Boston, Massachusetts, is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. The firm utilizes genetic insights to advance its drug development through two platforms: Cerebrum, a small-molecule platform, and Solidus, an antisense oligonucleotide platform. The company has a market capitalization of $4.7 billion and reported an EPS of -12.90 for the trailing twelve months.
Upcoming earnings are scheduled for August 3, 2026, with an estimated EPS of -3.48 and no projected revenue. While insider selling can occur for various reasons, it is essential for investors to consider such transactions in the context of broader insider activity and overall company fundamentals.